medigraphic.com
ISSN 1029-3035 (Electronic)

2015, Number 4

<< Back Next >>

Mediciego 2015; 21 (4)

Keratoacanthoma in HIV seropositive patient

del Río YMB, López VA, Hernández SJC, Valdés PE

Language: Spanish
References: 15
Page: 59-63
PDF size: 95.07 Kb.


ABSTRACT

Introduction: the keratoacanthoma is a benign tumor, crateriform, of a very rapid growth, with appearance of neoplasms. It’s characterized by its nodular form and the presence of a central corneal cap, as well as pseudoepitheliomatous hyperplasia which some authors have attributed to a viral origin. Usually occurs in areas exposed to sunlight in elderly adult or advanced age people, with a rapid growth from a rounded papule that overlay in the center. Regarding spontaneous regression, currently there is evidence that is immunologically mediated by activated lymphocytes T CD4–IL 2R; adhesion molecules play an important role in the immune response.
Case report: a 29 years old male patient, homosexual, HIV positive; was referred to the Dermatology specialist in his health area with a localized skin condition compatible with a giant keratoacanthoma that after starting antiretroviral therapy and a treatment with transfer factor (Hebertrans®), he regressed in three months.
Discussion: keratoacanthomas may be solitary or multiple. It has not been documented predilection for some sex, although some studies indicate that it is more common in males, with a ratio of 2:1. There are many therapeutic options but, despite scientific advances, surgery remains the treatment of choice, as in the cases of basal and squamous cell carcinomas.


REFERENCES

  1. Giraldo Nelson R, Falabella R. Queratoacantoma. En: Falabella R, editor. Fundamentos de Medicina. 5ta ed. Medellín: Corporación para Investigaciones Biológicas; 1997. p. 21-323.

  2. Mederos González AG. Otros tumores de la piel. En: Manzur J, Almeida Díaz J, Cortés M, editores. Dermatología. La Habana: Editorial de Ciencias Médicas; 2002. p. 272-84.

  3. Grados Beltrán G, Anaya Santos R. Queratoacantoma Subungueal: reporte de un caso. Dermatol Perú. 2003;13(1):65-7.

  4. Pinto de Gouveia Goncalves MJ. Manifestaciones cutáneas de infecciones virales en individuos infectados por el VIH [tesis]. Coimbra: Facultad de Medicina, Universidad de Coimbra; 2010.

  5. Fang CT, Chang YY, Hsu HM, Twu SJ, Chen KT, Lin CC, et al. Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antirretroviral therapy.QJM [Internet]. 2007 [citado 12 May 2015];100(2):97-105. Disponible en: http://qjmed.oxfordjournals.org/content/qjmed/100/2/97.full.pdf

  6. Gorriz JL, Gutiérrez F, Joan C Trullas, Arazo P, Arribas JR, Barril G, et al. Documento de consenso sobre el manejo de la patología renal en pacientes con infección por el VIH. Rev Nefrología (Madr.) [Internet]. 2014 [citado 12 May 2015];34(2):1-81. Disponible en: http://scielo.isciii.es/pdf/nefrologia/v34s2/documentos_01.pdf

  7. Prato de Ferreyra R, Rene Talavera AD, Panico Ximena K, Piccini D, Cuffini C. Queratoacantoma oral. Revisión de la literatura y comunicación de un caso. Rev Facul Cienc Méd [Internet]. 2009 [citado 12 May 2015];66(1):21-5. Disponible en: http://revista.webs.fcm.unc.edu.arRev.2009_Supl.1/Queratoacantoma_oral.pdf

  8. Ramos Villanueva TI, Pérez Alcalá D, Bojórquez Medina A, González Torres S, Merino Enríquez J. Queratoacantoma: ¿pseudocáncer o carcinoma epidermoide? Dermatol Rev Mex [Internet]. 2012 [citado 26 Abr 2015];56(1):26-9. Disponible en: http://www.medigraphic.com/pdfs/derrevmex/rmd-2012/rmd121d.pdf

  9. Deza Mendoza HM. Características clínicas y epidemiológicas del cáncer de piel no melanoma [tesis]. Trujillo: Universidad Nacional de Trujillo; 2013.

  10. Oliver M. Tumores epidérmicos benignos. En: Lugo Rondón JA, editor. Dermatología. Caracas: Industria Editorial Venezolana; 1995. p. 1095-107.

  11. Alcalá D, Gutiérrez R, Gutiérrez RM, Medina A, Ramos Garibay A. Queratoacantoma. Rev Cent Dermatol Pascua [Internet]. 2003 [citado 12 May 2015];12(3):126-30. Disponible en: http://www.medigraphic.com/pdfs/derma/cd-2003/cd033d.pdf

  12. Isaguirre Vera DS, Rosales Narváez V, Gamboa Rangel L, Caire Tousaint S, Ávalos Fonte V, Cherit Domínguez J. Epidemiología del queratoacantoma en el Hospital General “Dr. Manuel Gea González”. Dermatol CMQ [Internet]. 2008 [citado 12 May 2015];6(1):8-14. Disponible en: http://www.medigraphic.com/pdfs/cosmetica/dcm-2008/dcm081b.pdf

  13. Colmenares LM, Zuluaga MA, Gallego P, Martínez WJ. Metástasis cutánea de un carcinoma de pulmón simulando un queratoacantoma. Rev CES Med [Internet]. 2013 [citado 12 May 2015];27(1):108-12. Disponible en: http://www.scielo.org.co/pdf/cesm/v27n1/v27n1a12.pdf

  14. Min Gun Y, Il-Hwan K. Intralesional Methotrexate for the treatment of keratoacanthoma: Retrospective study and review of the korean literature. Ann Dermatol [Internet]. 2014 [citado 12 May 2015];26(2):172-6. Disponible en: http://synapse.koreamed.org/Synapse/Data/PDFData/0140AD/ad-26-172.pdf

  15. Giglio P, Bravo F, Del Solar M, Salomón M, Puell L, Feria K, et al. Queratoacantomas múltiples: un reto diagnóstico y terapéutico. Folia Dermatol [Internet]. 2011 [citado 12 May 2015];22(1):17-24. Disponible en: http://revistas.concytec.gob.pe/pdf/fdp/v22n1/a03v22n1.pdf




2020     |     www.medigraphic.com